Assignee
NATIMAB THERAPEUTICS S R L
IT·0 granted patents·2 pending applications·0 citations·filing 2013–2017
Technology mixG01N2
Top patents by PatentIndex Score
2 records- 0143US2018188255A1Method for the in vitro diagnosis of pancreatic ductal adenocarcinoma or for determining the predisposition to pancreatic ductal adenocarcinomaNATIMAB THERAPEUTICS S R L·Filed 2017·Application pending·0 cites
- 0240US2015177249A1Method and a kit for the in vitro diagnosis of pancreatic ductal adenocarcinoma or for determining the predisposition to pancreatic ductal adenocarcinomaNATIMAB THERAPEUTICS S R L·Filed 2013·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when NATIMAB THERAPEUTICS S R L files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →